Patent details

EP3220891 Title: SUBLINGUAL FORMULATION OF RILUZOLE

Basic Information

Publication number:
EP3220891
PCT Application Number:
US2015061114
Type:
European Patent Granted for LU
Legal Status:
In force
Application number:
EP158234153
PCT Publication Number:
WO2016081472
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
SUBLINGUAL FORMULATION OF RILUZOLE
French Title of Invention:
FORMULATION SUBLINGUALE DE RILUZOLE
German Title of Invention:
SUBLINGUALE FORMULIERUNG VON RILUZOL
SPC Number:

Dates

Filing date:
17/11/2015
Grant date:
24/07/2019
EP Publication Date:
27/09/2017
PCT Publication Date:
26/05/2016
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
24/07/2019
EP B1 Publication Date:
24/07/2019
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
Expiration date:
17/11/2035
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
25/10/2019
 
 

Name:
Biohaven Therapeutics Ltd.
Address:
215 Church Street, New Haven, CT 06510, United States (US)

History of Owners

From:
17/07/2019
To:
25/10/2019

Name:
Biohaven Pharmaceutical Holding Company Ltd.
Address:
234 Church Street Suite 301, New Haven, CT 06520, United States (US)

Agent

Name:
MARKS & CLERK LLP
From:
01/10/2019
Address:
BP 1775, 1017, LUXEMBOURG, Luxembourg (LU)
To:

Inventor

1

Name:
VLADYKA, Ronald, Samuel
Address:
United States (US)

2

Name:
YU, Danny
Address:
United States (US)

3

Name:
SALEH, Amgad
Address:
United States (US)

4

Name:
CORIC, Vladimir
Address:
United States (US)

5

Name:
BERMAN, Robert, M.
Address:
United States (US)

Priority

Priority Number:
201462083094 P
Priority Date:
21/11/2014
Priority Country:
United States (US)

Classification

IPC classification:
A61K 9/00; A61K 9/08; A61K 9/20; A61K 31/428;

Publication

European Patent Bulletin

1

Issue number:
201930
Publication date:
24/07/2019
Description:
Grant (B1)

2

Issue number:
201934
Publication date:
21/08/2019
Description:
Application number/publication number of the divisional application (Art. 76) changed

3

Issue number:
201948
Publication date:
27/11/2019
Description:
Transfer of Rights

Annual Fees

Annual Fee Due Date:
01/12/2025
Annual Fee Number:
11
Annual Fee Amount:
148 Euro
Expected Payer:
Last Annual Fee Payment Date:
13/11/2024
Last Annual Fee Paid Number:
10
Last Annual Fee Paid Amount:
131 Euro
Payer:
CPA GLOBAL THE IP PLATFORM
Filing date Document type Number of pages
01/10/2019 Power Of Attorney 1
04/10/2019 Outgoing Correspondence 1
12/08/2022 Request For Change 1
02/09/2022 Outgoing Correspondence 56